← Back to home
Comparison · Analytics

DoseFinding vs sparsevctrs

A side-by-side editorial comparison of DoseFinding and sparsevctrs — release velocity, themes, recent moves, and the top alternatives to consider.

DoseFinding vs sparsevctrs: at a glance

FeatureDoseFindingsparsevctrs
SectorAnalyticsAnalytics
Velocity score0.00.0
Sparks · 30d00
Top themesdose-response, mcp-mod, clinical-trials, model-averagingsparse-data, tidymodels, altrep, numerical-computing
Last editorial update1h ago1h ago
WebsiteVisit →Visit →

What is DoseFinding?

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

Read the full DoseFinding trajectory →

What is sparsevctrs?

Sparse vectors stopped being a storage trick and became something you can do arithmetic on

sparsevctrs supplies sparse vectors that live inside ordinary data frames and tibbles, which is what lets tidymodels carry wide, mostly-zero feature matrices without densifying them. Through 0.2.0 and 0.3.0 the package built out a computation layer on top of that storage — first summary statistics, then scalar and element-wise arithmetic — and everything since has been correctness work at the C level.

Read the full sparsevctrs trajectory →

DoseFinding vs sparsevctrs: editorial side-by-side

D
DoseFinding
ANALYTICS
0.0

New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing

◆ Current state

DoseFinding implements MCP-Mod and related dose-response methodology for clinical trial design and analysis. In 2024 it changed hands — Marius Thomas took over as maintainer, Novartis was recorded as copyright holder and funder, and the package moved to the openpharma GitHub organisation with roxygen documentation and a proper NEWS file. The two releases since have added substantive methodology: model averaging for dose-response fitting in 1.3-1, and conditional and predictive power for interim analyses in 1.4-1.

◆ Where it's heading

The pattern before the handover was maintenance — R-devel compliance, a bug fix, a link. After it, each release carries a named methodological addition with an acknowledged contributor, plus documentation to match: a longitudinal analysis vignette shipped alongside the interim power work. Housekeeping continues underneath, mostly clearing deprecated ggplot2 interfaces, aes_string in one release and qplot in the next.

◆ Prediction

Given the last two releases each added one method with a supporting vignette, expect the next to follow the same shape. Both additions so far extend the package beyond fixed dose-response fitting, so adaptive and interim methodology is the more likely direction.

S
sparsevctrs
ANALYTICS
0.0

Sparse vectors stopped being a storage trick and became something you can do arithmetic on

◆ Current state

sparsevctrs supplies sparse vectors that live inside ordinary data frames and tibbles, which is what lets tidymodels carry wide, mostly-zero feature matrices without densifying them. Through 0.2.0 and 0.3.0 the package built out a computation layer on top of that storage — first summary statistics, then scalar and element-wise arithmetic — and everything since has been correctness work at the C level.

◆ Where it's heading

The release pattern splits cleanly at 0.3.0. Before it, new functions arrive in batches; after it, five consecutive releases are bug fixes, and the bugs are the kind that come with hand-written sparse kernels: a stack imbalance when sparse_multiplication() returns all zeros, undefined behaviour in multiplication, type errors in sparse_is_na(), coercion failures on NA input. That is the expected cost of an ALTREP-backed numerical layer, and the fixes are landing steadily.

◆ Prediction

With the arithmetic surface in place and the recent releases all narrow fixes, the next one is more likely another correctness patch than a new function family. The R devel fix in 0.3.5 suggests upcoming R releases are the current source of breakage.

Alternatives to DoseFinding and sparsevctrs

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DoseFinding or sparsevctrs.

See all DoseFinding alternatives → · See all sparsevctrs alternatives →

Recent activity from DoseFinding and sparsevctrs

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 8mo agosparsevctrsSparse character vector fix for R devel
  2. 1y agoDoseFindingConditional and predictive power for interim analyses
  3. 1y agosparsevctrsStack imbalance in sparse multiplication fixed
  4. 1y agosparsevctrsSparse matrix coercion no longer errors on NA input
  5. 1y agosparsevctrssparsity() fixed for classed numeric vectors
  6. 1y agosparsevctrsUndefined behaviour in sparse multiplication fixed
  7. 1y agoDoseFindingModel averaging arrives for dose-response fitting
  8. 1y agosparsevctrsScalar and element-wise arithmetic for sparse vectors
  9. 1y agoDoseFindingPackage moves to openpharma under new maintainership
  10. 2y agoDoseFindingCompliance update for R-devel
  11. 3y agoDoseFindingpowMCTBinCount bug fix

Frequently asked questions

What is the difference between DoseFinding and sparsevctrs?

They serve adjacent needs but don't currently overlap on shipped themes. DoseFinding and sparsevctrs are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is DoseFinding better than sparsevctrs?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DoseFinding and sparsevctrs are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to DoseFinding?

Top DoseFinding alternatives in Analytics are ranked by recent ship velocity. Browse the "DoseFinding alternatives" section above for the current picks, or visit /alternatives/dosefinding for the full list with editorial commentary on each.

What are the best alternatives to sparsevctrs?

Top sparsevctrs alternatives in Analytics are ranked by recent ship velocity. Browse the "sparsevctrs alternatives" section above for the current picks, or visit /alternatives/sparsevctrs for the full list with editorial commentary on each.